Plain-English translation of NCT06872567 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a new treatment called genicular artery embolization (GAE) using resorbable microspheres for people with knee osteoarthritis pain. Researchers want to see if this minimally invasive procedure โ which uses tiny beads delivered through blood vessels to reduce pain โ works as well as or better than a steroid injection directly into the knee joint. This treatment is designed for people whose knee pain hasn't responded well to other options.
Many people with knee arthritis struggle with chronic pain that limits their daily activities, and current treatments like steroid injections don't always provide lasting relief. This trial exists to test whether this new procedure could offer patients a better or longer-lasting option for managing their pain.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will be randomly assigned to receive either the new genicular artery embolization procedure or a steroid injection into your knee. The procedure involves a small incision to access blood vessels and deliver tiny beads to reduce pain, while the injection is a more traditional approach. You will attend follow-up visits to track how well the treatment works for your pain and function over time.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States
Sponsor
North American Science Associates Ltd.
Collaborators
Next Biomedical Co., Ltd.
Enrollment target
~126 participants
Started
October 2025
Primary completion
June 2026
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
40 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Ziv J Haskal, MD
North American Science Associates Ltd.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.